ENOX1-AS2

Across TCGA pan-cancer cohorts, ENOX1-AS2 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated ENOX1-AS2 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ENOX1-AS2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ENOX1-AS2 expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

BLCA, PAAD, and ESCA are the cancer types where ENOX1-AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.373	0.641	<.001	99	view →
PAAD	OS	Tertile	II,III,IV	0.037	0.621	<.001	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
THYM	OS	Tertile	All	0.858	0.982	<.001	33	view →
THCA	DFS	Tertile	IV	0.144	0.884	<.001	27	view →
LUSC	OS	Tertile	III,IV	0.265	0.688	.030	27	view →
KIRP	OS	Tertile	III,IV	0.268	0.808	.012	18	view →
SKCM	DFS	Tertile	IV	0.040	0.454	.028	18	view →
LGG	DFS	Quartile	All	0.720	0.382	.018	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

ENOX1-AS2–BLCA (DFS)

Open the BLCA breakdown →